Decreased myocardial free fatty acid uptake in patients with idiopathic dilated cardiomyopathy: evidence of relationship with insulin resistance and left ventricular dysfunction.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Cardiac Failure

• Publication date

  2006-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.CARDFAIL.2006.06.005PMID 17045185
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Metabolic Modulation With Perhexiline in Chronic Heart Failure: A Randomized, Controlled Trial of Short-Term Use of a Novel Treatment

  2005cited by this paper
• Selective versus nonselective β‐adrenergic receptor blockade in chronic heart failure: differential effects on myocardial energy substrate utilization

  2005cited by this paper
• Clinical research: heart failureInsulin resistance in idiopathic dilated cardiomyopathy: A possible etiologic link

  2004cited by this paper
• Effect of Obesity and Insulin Resistance on Myocardial Substrate Metabolism and Efficiency in Young Women

  2004cited by this paper
• Trimetazidine improves left ventricular function and quality of life in elderly patients with coronary artery disease.

  2004cited by this paper
• Myocardial perfusion reserve and oxidative metabolism contribute to exercise capacity in patients with dilated cardiomyopathy.

  2004cited by this paper
• Heart Physiology: From Cell to Circulation

  2003cited by this paper
• Insulin resistance in dilated cardiomyopathy.

  2003cited by this paper
• Effect of beta-blockers on insulin resistance in patients with dilated cardiomyopathy.

  2003cited by this paper
• Short- and long-term beneficial effects of trimetazidine in patients with diabetes and ischemic cardiomyopathy.

  2003cited by this paper
• Effect of selective and nonselective beta-blockers on resting energy production rate and total body substrate utilization in chronic heart failure.

  2002cited by this paper
• Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy.

  2002cited by this paper
• Clinical significance of the insulin resistance index as assessed by homeostasis model assessment.

  2001cited by this paper
• Myocardial Free Fatty Acid and Glucose Use After Carvedilol Treatment in Patients With Congestive Heart Failure

  2001cited by this paper
• Myocardial fatty acid oxidation in patients with impaired glucose tolerance

  2001cited by this paper
• Postinfarction heart failure in rats is associated with upregulation of GLUT-1 and downregulation of genes of fatty acid metabolism.

  2001cited by this paper
• Homeostasis model assessment is a reliable indicator of insulin resistance during follow-up of patients with type 2 diabetes.

  2001cited by this paper
• An evaluation of myocardial fatty acid and glucose uptake using PET with [18F]fluoro-6-thia-heptadecanoic acid and [18F]FDG in Patients with Congestive Heart Failure.

  2001cited by this paper
• Celiprolol augments the effect of physical exercise on insulin sensitivity and serum lipid levels in chronic heart failure

  2000cited by this paper
• Carvedilol does not alter the insulin sensitivity in patients with congestive heart failure

  2000cited by this paper
• Fatty acid utilization in the hypertrophied and failing heart: molecular regulatory mechanisms.

  1999cited by this paper
• Free fatty acid kinetics and oxidation in congestive heart failure.

  1998cited by this paper
• Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure.

  1997cited by this paper
• Fatty acid oxidation enzyme gene expression is downregulated in the failing heart.

  1996cited by this paper
• Myocardial blood flow: comparison of oxygen-15-water bolus injection, slow infusion and oxygen-15-carbon dioxide slow inhalation.

  1995cited by this paper
• Total-body and myocardial substrate oxidation in congestive heart failure.

  1994cited by this paper
• ß1‐ and ß2‐antagonist activity of topically applied betaxolol and timolol in the systemic circulation

  1993cited by this paper
• Beta 1- and beta 2-antagonist activity of topically applied betaxolol and timolol in the systemic circulation.

  1993cited by this paper
• Use of the left ventricular time-activity curve as a noninvasive input function in dynamic oxygen-15-water positron emission tomography.

  1992cited by this paper
• A sensitive radioligand binding assay for timolol in plasma.

  1991cited by this paper
• Plasma 3,4-dihydroxyphenylglycol (DHPG) and 3-methoxy-4-hydroxyphenylglycol (MHPG) are insensitive indicators of alpha 2-adrenoceptor mediated regulation of norepinephrine release in healthy human volunteers.

  1991cited by this paper
• Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings.

  1986cited by this paper
• Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man

  1985cited by this paper
• Preparation of [1-11C]acetate--an agent for the study of myocardial metabolism by positron emission tomography.

  1982cited by this paper
• [1-(11)C]palmitic acid: improved radiopharmaceutical preparation.

  1982cited by this paper
• Recommendations Regarding Quantitation in M-Mode Echocardiography: Results of a Survey of Echocardiographic Measurements

  1978cited by this paper
• Rapid enzymatic measurement of blood lactate and pyruvate. Use and significance of metaphosphoric acid as a common precipitant.

  1967cited by this paper

• Imaging of metabolic dysfunction in genetic cardiomyopathies

  2025cites this paper
• Metabolic Modulation in Dilated Cardiomyopathy: From Pathophysiology to Therapy

  2025cites this paper
• Human cardiac metabolism.

  2024cites this paper
• Advances in myocardial energy metabolism: metabolic remodelling in heart failure and beyond

  2024cites this paper
• Cardiac Metabolism in Heart Failure and Implications for Uremic Cardiomyopathy

  2023cites this paper
• Driving force of deteriorated cellular environment in heart failure: Metabolic remodeling

  2023cites this paper
• Stimulation of the Hydroxycarboxylic Acid Receptor 2 With the Ketone Body 3‐Hydroxybutyrate and Niacin in Patients With Chronic Heart Failure: Hemodynamic and Metabolic Effects

  2023cites this paper
• Insulin resistance and metabolic flexibility as drivers of liver and cardiac disease in T2DM.

  2023cites this paper
• Integrated Control of Fatty Acid Metabolism in Heart Failure

  2023cites this paper
• Metabolomic Profiling of End-Stage Heart Failure Secondary to Chronic Chagas Cardiomyopathy

  2022cites this paper
• Impact of type 2 diabetes mellitus on left ventricular deformation in non-ischemic dilated cardiomyopathy patients assessed by cardiac magnetic resonance imaging

  2022cites this paper
• Iron Deficiency and Deranged Myocardial Energetics in Heart Failure

  2022cites this paper
• Review of Insulin Resistance in Dilated Cardiomyopathy and Implications for the Pediatric Patient Short Title: Insulin Resistance DCM and Pediatrics

  2021cites this paper
• Cardiac-specific microRNA-125b deficiency induces perinatal death and cardiac hypertrophy

  2021cites this paper
• PET imaging in diabetic cardiomyopathy

  2021cites this paper
• Optimizing the discovery and assessment of therapeutic targets in heart failure with preserved ejection fraction

  2021cites this paper
• Oxidative metabolism and cardiac work in different heart failure phenotypes.

  2021cites this paper
• Free fatty acids and heart failure in the Multi-Ethnic Study of Atherosclerosis (MESA).

  2021cites this paper
• Lipid in the midst of metabolic remodeling - Therapeutic implications for the failing heart.

  2020cites this paper
• CardiacApplications of Radiopharmaceuticals

  2020cites this paper
• Myocardial glucose and fatty acid metabolism is altered and associated with lower cardiac function in young adults with Barth syndrome

  2019cites this paper
• Is it time to reassess the role of myocardial metabolic modulation for the treatment of heart failure?

  2019cites this paper
• Cardiac manifestations of inherited metabolic disease linked to cellular metabolism of vitamin B12 : study in two murine models of invalidation of Mtr and MMACHC genes

  2019cites this paper
• What fuels the failing heart ?

  2019cites this paper
• PET Imaging of Myocardial Metabolism in Health and Disease

  2019cites this paper
• Oleic Acid Prevents Isoprenaline-Induced Cardiac Injury: Effects on Cellular Oxidative Stress, Inflammation and Histopathological Alterations

  2019cites this paper
• Cardiovascular Effects of Treatment With the Ketone Body 3-Hydroxybutyrate in Chronic Heart Failure Patients

  2019cites this paper
• Loss of Metabolic Flexibility in the Failing Heart

  2018cites this paper
• Metabolic Coordination of Physiological and Pathological Cardiac Remodeling

  2018cites this paper
• Abnormal Myocardial Dietary Fatty Acid Metabolism and Diabetic Cardiomyopathy.

  2018cites this paper
• Imaging myocardial metabolism

  2018cites this paper
• Contemporary Advances in Myocardial Metabolic Imaging and Their Impact on Clinical Care: a Focus on Positron Emission Tomography (PET)

  2018cites this paper
• Metabolic remodeling in hypertrophied and failing myocardium: a review.

  2017cites this paper
• Molecular Changes in Heart Failure

  2017cites this paper
• Cardiovascular consequences of metabolic syndrome.

  2017cites this paper
• Effect of long fasting on myocardial accumulation in 18F-fluorodeoxyglucose positron emission tomography after chemoradiotherapy for esophageal carcinoma

  2017cites this paper
• Increased de novo ceramide synthesis and accumulation in failing myocardium.

  2017cites this paper
• Sex affects myocardial blood flow and fatty acid substrate metabolism in humans with nonischemic heart failure

  2017cites this paper
• Metabolomic Analysis in Heart Failure.

  2017cites this paper
• Metabolic profiles in heart failure due to non‐ischemic cardiomyopathy at rest and under exercise

  2017cites this paper
• Maternal Obesity and Cardiac Development in the Offspring: Study in Human Neonates and Minipigs.

  2017cites this paper
• Increased de novo ceramide synthesis and accumulation in failing myocardium.

  2017cites this paper
• HEMODYNAMIC AND CARDIAC EFFECTS OF OBESITY AND THE METABOLIC SYNDROME

  2017cites this paper
• Mitochondrial Function in Non-ischemic Heart Failure.

  2017cites this paper
• Obesity, Diabetes, and Cardiovascular Diseases Compendium Lipid Use and Misuse by the Heart

  2016cites this paper
• Schulze et al Cardiac Lipotoxicity 1737 Evidence of Lipotoxicity in the Human Heart

  2016cites this paper
• Diabetic glucolipotoxic cardiomyopathy : does it exist in humans ?

  2016cites this paper
• Effects of exenatide on cardiac function, perfusion, and energetics in type 2 diabetic patients with cardiomyopathy: a randomized controlled trial against insulin glargine

  2016cites this paper
• Imaging of myocardial fatty acid oxidation.

  2016cites this paper
• Circulating endothelial-derived apoptotic microparticles and insulin resistance in non-diabetic patients with chronic heart failure

  2016cites this paper
• Evidence for Intramyocardial Disruption of Lipid Metabolism and Increased Myocardial Ketone Utilization in Advanced Human Heart Failure

  2016cites this paper
• Elevated Glucose Oxidation, Reduced Insulin Secretion, and a Fatty Heart May Be Protective Adaptions in Ischemic CAD

  2016cites this paper
• Left ventricular vascular and metabolic adaptations to high‐intensity interval and moderate intensity continuous training: a randomized trial in healthy middle‐aged men

  2016cites this paper
• Lipid Use and Misuse by the Heart.

  2016cites this paper
• Positron emission tomography: An additional prognostic tool in dilated cardiomyopathy?

  2016cites this paper
• IMPAIRED IMMUNE PHENOTYPE OF CIRCULATING ENDOTHELIAL- DERIVED MICROPARTICLES IN NONE-DIABETIC PATIENTS WITH CHRONIC HEART FAILURE: IMPACT ON INSULIN RESISTANCE

  2015cites this paper
• Cross-Talk Between Adipose Tissue Health, Myocardial Metabolism and Vascular Function: The Adipose-Myocardial and Adipose-Vascular Axes.

  2015cites this paper
• C-11 acetate has excellent reproducibility for quantification of myocardial oxidative metabolism.

  2015cites this paper
• An Association of Insulin Resistance with Numerous of Circulating Microparticles Originated from Endothelial Cells in Cardiac Failure Individuals without History of Diabetes Mellitus

  2015cites this paper
• Interrelationship between insulin resistance and impaired immune phenotype of circulating endothelial-derived microparticles in none-diabetic patients with chronic heart failure

  2015cites this paper
• Metabolic efficiency in remodeled failing hearts

  2015cites this paper
• Cardioprotective effects of dietary lipids evident in the time‐dependent alterations of cardiac function and gene expression following myocardial infarction

  2014cites this paper
• Metabolomic Analysis of Pressure-Overloaded and Infarcted Mouse Hearts

  2014cites this paper
• Relationship between circulating endothelial progenitor cells and insulin resistance in non-diabetic patients with ischemic chronic heart failure.

  2014cites this paper
• Impact of glucagon-like peptide-1 on myocardial glucose metabolism revisited

  2014cites this paper
• Metabolic remodeling in chronic heart failure

  2013cites this paper
• Plasma Free Fatty Acids and Risk of Heart Failure: The Cardiovascular Health Study

  2013cites this paper
• Alterations in mitochondrial function in cardiac hypertrophy and heart failure

  2013cites this paper
• Imaging metabolism and perfusion in patients with diabetes and heart failure

  2013cites this paper
• Perivascular adipose tissue in the pathogenesis of cardiovascular disease.

  2013cites this paper
• A “PET” area of interest: myocardial metabolism in human systolic heart failure

  2013cites this paper
• The Failing Heart: Is It an Inefficient Engine or an Engine Out of Fuel?

  2013cites this paper
• Characterizing the Relationship Between Energy Metabolism and Mesenchymal Stem Cell Therapy in the Infarcted Heart

  2013cites this paper
• Pressure-overload-induced heart failure induces a selective reduction in glucose oxidation at physiological afterload.

  2013cites this paper
• Recent advances in metabolic imaging

  2013cites this paper
• Glucose-insulin-potassium revived: current status in acute coronary syndromes and the energy-depleted heart.

  2013cites this paper
• Mesenchymal stem cell transplantation for the infarcted heart: a role in minimizing abnormalities in cardiac-specific energy metabolism.

  2012cites this paper
• Targeting myocardial substrate metabolism in heart failure: potential for new therapies

  2012cites this paper
• Insulin sensitization therapy and the heart: focus on metformin and thiazolidinediones.

  2012cites this paper
• Mitochondrial Approaches to Protect Against Cardiac Ischemia and Reperfusion Injury

  2011cites this paper
• Effect of canrenone on left ventricular mechanics in patients with mild systolic heart failure and metabolic syndrome: the AREA-in-CHF study.

  2011cites this paper
• Chapter 50 – Emerging Strategies in the Treatment of Heart Failure

  2011cites this paper
• Risk stratification for cardiac death in hemodialysis patients without obstructive coronary artery disease.

  2011cites this paper
• Chapter 16 – Alterations in the Sympathetic and Parasympathetic Nervous Systems in Heart Failure

  2011cites this paper
• Effect of Diabetes on Alteration of Metabolism in Cardiac Myocytes: Therapeutic Implications

  2011cites this paper
• Metabolic remodelling in human heart failure.

  2011cites this paper
• Chapter 40 – Imaging of Myocardial Metabolism

  2010cites this paper
• Ectopic fat and cardiovascular disease: what is the link?

  2010cites this paper
• Suppression of circulating free fatty acids with acipimox in chronic heart failure patients changes whole body metabolism but does not affect cardiac function.

  2010cites this paper
• Metabolic toxicity of the heart: insights from molecular imaging.

  2010cites this paper
• Metabolic imaging in myocardial ischemia and heart failure.

  2010cites this paper
• What We Know and Do Not Know about Sex and Cardiac Disease

  2010cites this paper
• Energetics and metabolism in the failing heart: important but poorly understood

  2010cites this paper
• Decreased rates of substrate oxidation ex vivo predict the onset of heart failure and contractile dysfunction in rats with pressure overload.

  2010cites this paper
• Myocardial Metabolism in Health and Disease

  2010cites this paper
• Contemporary Reviews in Cardiovascular Medicine

  2010cites this paper
• Impaired glucose tolerance and insulin resistance in heart failure: underrecognized and undertreated?

  2010cites this paper
• Metabolic remodelling of the failing heart: beneficial or detrimental?

  2009cites this paper
• Diabetes Does Not Affect Ventricular Repolarization and Sudden Cardiac Death Risk in Patients with Dilated Cardiomyopathy

  2009cites this paper
• Translation of myocardial metabolic imaging concepts into the clinics.

  2009cites this paper